Depressive Disorder News and Research RSS Feed - Depressive Disorder News and Research

Study finds dramatic increase in nonmedical use of prescription opioids in the U.S.

Study finds dramatic increase in nonmedical use of prescription opioids in the U.S.

Nonmedical use of prescription opioids more than doubled among adults in the United States from 2001-2002 to 2012-2013, based on a study from the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health. Nearly 10 million Americans, or 4.1 percent of the adult population, used opioid medications in 2012-2013 a class of drugs that includes OxyContin and Vicodin, without a prescription or not as prescribed (in greater amounts, more often, or longer than prescribed) in the past year. [More]
Mayo Clinic highlights potential merits of individualizing treatment for patients taking antidepressants

Mayo Clinic highlights potential merits of individualizing treatment for patients taking antidepressants

Mayo Clinic is highlighting the potential merits of using precision medicine in prescribing antidepressants. Details appear in the current issue of Mayo Clinic Proceedings. [More]
Study shows childhood adversities, sleep disturbances interfere with immune system regulation

Study shows childhood adversities, sleep disturbances interfere with immune system regulation

Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland. [More]
Childhood exposure to chronic parental domestic violence linked to suicide attempts among adults

Childhood exposure to chronic parental domestic violence linked to suicide attempts among adults

A new study by the University of Toronto, found the lifetime prevalence of suicide attempts among adults who had been exposed to chronic parental domestic violence during childhood was 17.3% compared to 2.3% among those without this childhood adversity. [More]
New research offers hope for patients struggling with major depression

New research offers hope for patients struggling with major depression

A new study reports that approximately two in five adults (39%) who have experienced major depression are able to achieve complete mental health. Researchers consider complete mental health as occurring when people achieve almost daily happiness or life satisfaction, positive social and psychological well-being, and are also free of depression, anxiety, suicidal thoughts and substance abuse for at least one full year. [More]
GET.ON online training course can effectively reduce depression risk

GET.ON online training course can effectively reduce depression risk

Inspired by promising tests of web-based health intervention measures, the researchers aimed to find out whether the risk of developing depression could be reduced by a six-week online training course called GET.ON. GET.ON is based on established therapy methods involving systematic problem solving and behavioural activation. [More]
Study shows non-Hispanic blacks less likely to receive treatment for schizophrenia

Study shows non-Hispanic blacks less likely to receive treatment for schizophrenia

Non-Hispanic blacks are almost twice as likely as non-Hispanic whites to be diagnosed with schizophrenia, but they're significantly less likely to receive medication for treatment, according to researchers. [More]
Study demonstrates effectiveness of NeuroStar TMS Therapy System in women with postpartum depression

Study demonstrates effectiveness of NeuroStar TMS Therapy System in women with postpartum depression

An unfortunate fact facing mothers in the U.S. is that postpartum depression is the most common complication of childbirth. Approximately 10 to 15 percent of women who give birth each year – or roughly 600,000 women – experience postpartum depression symptoms. [More]
New study links altered purine metabolism to major depressive disorder

New study links altered purine metabolism to major depressive disorder

People suffering from major depressive disorder may have altered purine metabolism, according to a new study from the University of Eastern Finland and Kuopio University Hospital. [More]
Low adiponectin levels may lead to development of PTSD symptoms

Low adiponectin levels may lead to development of PTSD symptoms

Individuals with post-traumatic stress disorder (PTSD) relive past traumas again and again, bound in a virtual prison of their memories. [More]
Study shows risk of developing MDD depends on symptom centrality in network

Study shows risk of developing MDD depends on symptom centrality in network

A novel study published in the current issue of Psychotherapy and Psychosomatics discloses how depression may develop. [More]

Mindfulness-based cognitive therapy more beneficial without antidepressant drugs

An investigation published in the current issue of Psychotherapy and Psychosomatics indicates that mindfulness based cognitive therapy (MBCT) is most helpful when antidepressant drugs are not used. [More]
Neuroimaging studies offer new insights into cognitive vulnerability to depression

Neuroimaging studies offer new insights into cognitive vulnerability to depression

Neuroimaging studies of interconnected brain networks may provide the "missing links" between behavioral and biological models of cognitive vulnerability to depression, according to a research review in the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer. [More]
Depressed moms not physiologically 'in sync' with their children

Depressed moms not physiologically 'in sync' with their children

Mothers with a history of depression are not physiologically "in sync" with their kids, according to a new study from Binghamton University. While researchers have known for a while that depression is associated with interpersonal problems with others, this is the first study to examine whether this is also evident physiologically. [More]
RADAR-CNS programme aims to improve lives of patients with brain disorders

RADAR-CNS programme aims to improve lives of patients with brain disorders

A major new research program supported by the Innovative Medicines Initiative launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology. [More]
New meta-analysis supports link between intake of omega-3 fatty acids and reduction in MDD

New meta-analysis supports link between intake of omega-3 fatty acids and reduction in MDD

According to the World Health Organization, depression is a major cause of disease burden worldwide, affecting an estimated 350 million people. According to the National Institutes of Mental Health, in 2014, an estimated 15.7 million adults aged 18 or older in the United States had at least one major depressive episode in the past year. [More]
Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe. [More]
New imaging study shows how exercise affects the brain

New imaging study shows how exercise affects the brain

People who exercise have better mental fitness, and a new imaging study from UC Davis Health System shows why. Intense exercise increases levels of two common neurotransmitters -- glutamate and gamma-aminobutyric acid, or GABA -- that are responsible for chemical messaging within the brain. [More]
Researchers explore effects of attention bias modification in adolescents with MDD

Researchers explore effects of attention bias modification in adolescents with MDD

A study to be published in the March 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that adolescents with major depression who performed a computer-based task designed to shift attention from sad to neutral to positive word associations showed reductions in negative attention biases and clinician-rated depressive symptoms. [More]
Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2015. [More]
Advertisement
Advertisement